NCCN Announces Funding for Early-Stage Non-Small Cell Lung Cancer Projects, in Collaboration with AstraZeneca

PLYMOUTH MEETING, Pa. The National Comprehensive Cancer Network ® ( NCCN ® ) Oncology Research Program ( ORP ) today announced new funding for projects to improve patient care and outcomes in early-stage non-small cell lung cancer (NSCLC). Funding will be provided through support from AstraZeneca.

Read the source article at PR Newswire
2021-11-11 15:35:00